
mbbirdy/E+ via Getty Images
Health Catalyst (NASDAQ:HCAT) traded lower for the third straight session on Monday as Citi became the latest brokerage to downgrade HCAT after the health tech firm’s lower-than-expected Q2 2025 financials last week.
Citi analyst Daniel Grosslight downgraded the company to